title: Primary CNS lymphoma: a landmark trial and the next steps.
authors.affiliation: From the Departments of Neurology and Neurosurgery (E.A.N.), Oregon Health & Science University, Portland; the Portland Veterans Affairs Medical Center (E.A.N.), OR; and the University of Virginia Neuro-Oncology Center (D.S.), Charlottesville. neuwelte@ohsu.edu.
authors.forename: Edward A
authors.initials: EA
authors.lastname: Neuwelt
authors.affiliation: From the Departments of Neurology and Neurosurgery (E.A.N.), Oregon Health & Science University, Portland; the Portland Veterans Affairs Medical Center (E.A.N.), OR; and the University of Virginia Neuro-Oncology Center (D.S.), Charlottesville.
authors.forename: David
authors.initials: D
authors.lastname: Schiff
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D016371:Cranial Irradiation / Q000379:methods*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate